2014
DOI: 10.1007/s00405-014-3160-x
|View full text |Cite
|
Sign up to set email alerts
|

Atypical mycobacteriosis in children: a diagnostic and therapeutic challenge

Abstract: Atypical mycobacteriosis (AM) is a rare disease, which is caused by an infection with mycobacteria other than tuberculosis (MOTT). In children, the cervical lymph nodes are frequently affected. MOTT are a pathogen or facultative pathogen environmental germs, which can affect otherwise healthy individuals. The diagnostic and therapeutic management is often challenging. Currently, there are only few data published about the systematic investigation and therapy of children with AM. In a retrospective study, 29 ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 21 publications
0
6
0
1
Order By: Relevance
“…Cutaneous manifestations of MAC infection are rare and may include pustules, papules, erythematous plaques, painless yellow plaques, painful nodules, granulomas, abscesses, verrucous ulcers, ulcerations, and panniculitis and are most commonly localized to the head and neck. [4][5][6] The variable presentation of MAC infections and the difficulty of culture and proper identification of the organism on hematoxylin and eosin staining can pose a diagnostic challenge, as well as the histopathological findings that may mimic other conditions such as sarcoidosis, as in our case. In fact, several reports in the literature describe cases where mycobacterial cutaneous lesions were initially misdiagnosed as sarcoidosis.…”
Section: Discussionmentioning
confidence: 86%
“…Cutaneous manifestations of MAC infection are rare and may include pustules, papules, erythematous plaques, painless yellow plaques, painful nodules, granulomas, abscesses, verrucous ulcers, ulcerations, and panniculitis and are most commonly localized to the head and neck. [4][5][6] The variable presentation of MAC infections and the difficulty of culture and proper identification of the organism on hematoxylin and eosin staining can pose a diagnostic challenge, as well as the histopathological findings that may mimic other conditions such as sarcoidosis, as in our case. In fact, several reports in the literature describe cases where mycobacterial cutaneous lesions were initially misdiagnosed as sarcoidosis.…”
Section: Discussionmentioning
confidence: 86%
“…The patient in this study was initially treated in a combination method with complete excision followed by 12 months of rifabutin. At the time of recurrence this patient was treated with a 10‐month regime of clarithromycin, rifabutin, and ethambutol 13 . All studies described treating recurrence in a broad variety of ways.…”
Section: Resultsmentioning
confidence: 99%
“…Neven et al described that 54% ( n = 7) of cases treated with incomplete excision in their cohort required a second surgical intervention for complete excision due to persistent infection or recurrence occurring between 18 days and 25 months after the initial intervention 7 . Many of the included papers discussed the trend of initial complete excision being associated with lower rates of recurrence 1,7,9,13,14,18,22 . Another frequent discussion was the association between previous biopsy (incision and drainage or FNA) being associated with higher rates of recurrence, even after complete excision 7,16 .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Luong et al haben in ihrer Studie eine Kombination aus Clarithromycin und Ethambutol oder Rifampicin sowie aus Rifampicin und Isoniazid mit oder ohne Clarithromycin vorgezogen [20]. Lindeboom et al [21] haben eine Therapie mit der Kombination Clarithromycin-Rifabutin und Deichmueller et al [18] eine Monotherapie mit Clarithromycin oder eine Kombination von Clarithromycin mit entweder Rifampicin oder Rifabutin durchgeführt. Generell zeigt sich in der Literatur eine große Heterogenität bezüglich der verabreichten antibiotischen Schemata, die möglicherweise vom Zeitpunkt der Studie und der lokalen Therapieprotokolle abhängig sind.…”
Section: Materials Und Methodenunclassified